ZHENGYE BIOTECHNOLOGY HLDG L ORD SHS is a security (CUSIP G989MS101) tracked across SEC portfolio filings. 9 institutional managers reported $113K on Form 13F as of 2026-06-30.
| Manager | Location | Value | Shares |
|---|---|---|---|
| XTX Topco Ltd | LONDON, X0 | $41K | 44,146 |
| WINTON GROUP Ltd | LONDON, X0 | $31K | 33,389 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $27K | 29,068 |
| UBS Group AG | Zurich, V8 | $8K | 8,036 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $5K | 4,912 |
| Royal Bank of Canada | TORONTO, A6 | $1K | 1,230 |
| MORGAN STANLEY | NEW YORK, NY | $244 | 261 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $1 | 1 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |